Výsledky vyhledávání - "I. A. Ertuzun"

Release-Active Antibodies to S100 Protein Can Correct the Course of Experimental Allergic Encephalomyelitis

Autor: Yu. L. Dugina, O. I. Epshtein, I. N. Abdurasulova, K. S. Zhavbert, K. K. Ganina, I. A. Ertuzun

Publikováno v: Neuroscience and Behavioral Physiology. 47:163-167

Objective. To study the efficacy of release-active forms of antibody to S100 protein in an animal model of multiple sclerosis. Materials and methods. The study was performed on 60 female rats aged 12 weeks. Experimental allergic encephalomyelitis was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7c2351a040b45cacecbeafc73988acf
https://doi.org/10.1007/s11055-016-0380-0

Zobrazit plný text záznamu

In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form

Autor: I. A. Ertuzun, Sergey A. Tarasov, Evgeniy A. Gorbunov, E. V. Kachaeva, Oleg I. Epstein

Publikováno v: Neuropsychiatric Disease and Treatment

Evgeniy A Gorbunov, Irina A Ertuzun, Evgeniya V Kachaeva, Sergey A Tarasov, Oleg I EpsteinOOO “NPF “MATERIA MEDICA HOLDING”, Moscow, Russian FederationAbstract: Experimentally and clinically, it was shown that released-active form of antibodies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55d34de089525c9955f5b9fe58331db5
http://europepmc.org/articles/PMC4639559

Zobrazit plný text záznamu

Anaferon, released-active from of antibodies to interferon-gamma, as an effective medicine for treatment and prophylaxis of a wide spectrum of infections

Autor: Epstein Oi, Zabolotneva Ja, Tarasov Sa, E. A. Gorbunov, M. V. Kachanova, M.V. Borodavkina, M. V. Belopolskaya, Dugina Jl, I. A. Ertuzun

Publikováno v: Clinical Research and Trials. 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::192358533c558b664ed71a09e7284c5a
https://doi.org/10.15761/crt.1000152

Zobrazit plný text záznamu

Dose–Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light–Dark Test in Mice

Autor: Elena V. Kardash, Vladimir Ivashkin, Emile Andriambeloson, Sergey A. Tarasov, Stéphanie Wagner, Andrey N. Kolyadin, I. A. Ertuzun, Oleg I. Epstein, Gulnara Rinatovna Khakimova

Publikováno v: Dose-Response
Dose-Response, Vol 16 (2018)

Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4992f0762c6b39208e50ab9ad274ea
https://doi.org/10.1177/1559325818779752

Zobrazit plný text záznamu

[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis]

Autor: Yu. L. Dugina, Oleg I. Epstein, K. K. Ganina, E. S. Zhavbert, I. A. Ertuzun, I. N. Abdurasulova

Publikováno v: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 115(6)

To reveal the effects of release-active antibodies to S100 protein in an animal model of multiple sclerosis.Sixty female Wistar rats, aged 12 weeks, were included in the study. The pathology was induced by subcutaneous injection of the spinal cord ho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5766d4f33d46e08a5c0ebf5dc68643
https://pubmed.ncbi.nlm.nih.gov/26356401

Zobrazit plný text záznamu

Anxiolytic and Antidepressant Effects of Divaza and Brizantin

Autor: O. I. Epshtein, Molodavkin Gm, V. I. Poseva, M. A. Putilovskii, V. V. Andreeva, I. A. Ertuzun, Yu. L. Dugina, N. I. Suslov, N. N. Yakovleva, T. A. Voronina

Publikováno v: Bulletin of experimental biology and medicine. 159(6)

The anxiolytic and antidepressant activities of complex preparations divaza and brizantin containing antibodies to brain-specific protein S100 were estimated using Vogel conflict test and Nomura forced swimming test. Course treatment (5 days) of briz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e69c5b78f5f2ffb7e3aed8aec3f95b3
https://pubmed.ncbi.nlm.nih.gov/26519263

Zobrazit plný text záznamu

Antiamnesic effects divaza and its component model β-amyloid amnesia

Autor: E. S. Zhavbert, V. N. Mukhin, Yu. L. Duginа, I. N. Abdurasulova, K. K. Ganinа, I. A. Ertuzun, Oleg I. Epstein

Publikováno v: Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 116:69

On amnesia models induced by (icv) injection of β-amyloid fragment 25-35 peptide were evaluated antiamnestic actitity.It was used of active antibody preparations (RA AT) to protein S100 (tenoten), to eNOS (impaza) and combinations (divaza) antiamnes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ca3a073daf30e9876727569700da62a
https://doi.org/10.17116/jnevro20161169169-74

Zobrazit plný text záznamu

Farmacological effects of anti-S100 in release-active form and mechanisms of their realisation

Autor: Yu. L. Dugina, O. I. Epshtein, T. A. Voronina, G. R. Khakimova, I. A. Ertuzun

Publikováno v: Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 116:100

Antibodies to 5100 proteins (anti-5100) in release-active form (RA anti-5100) are an active component of some domestic drugs(tenoten, tenoten for children, divaza, brizantin, kolofort and proproten-100). The authors present the results of preclinical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7e36ff1d2bebdf931e98a741f83d1e
https://doi.org/10.17116/jnevro201611641100-113

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání